Global and Japan Gadobutrol (CAS 138071-82-6) Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Gadobutrol (CAS 138071-82-6) Product Introduction
1.2 Market Segments
1.3 Key Gadobutrol (CAS 138071-82-6) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gadobutrol (CAS 138071-82-6) Market Size Growth Rate by Type
1.4.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.4.3 Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
1.4.4 Pharmacy Bulk Packages (30 mL and 65 mL)
1.5 Market by Application
1.5.1 Global Gadobutrol (CAS 138071-82-6) Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Children
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gadobutrol (CAS 138071-82-6) Market Size, Estimates and Forecasts
2.1.1 Global Gadobutrol (CAS 138071-82-6) Revenue 2015-2026
2.1.2 Global Gadobutrol (CAS 138071-82-6) Sales 2015-2026
2.2 Global Gadobutrol (CAS 138071-82-6), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gadobutrol (CAS 138071-82-6) Historical Market Size by Region (2015-2020)
2.3.1 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gadobutrol (CAS 138071-82-6) Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2021-2026)
2.4.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2021-2026)
3 Global Gadobutrol (CAS 138071-82-6) Competitor Landscape by Players
3.1 Global Top Gadobutrol (CAS 138071-82-6) Sales by Manufacturers
3.1.1 Global Gadobutrol (CAS 138071-82-6) Sales by Manufacturers (2015-2020)
3.1.2 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gadobutrol (CAS 138071-82-6) Manufacturers by Revenue
3.2.1 Global Gadobutrol (CAS 138071-82-6) Revenue by Manufacturers (2015-2020)
3.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gadobutrol (CAS 138071-82-6) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gadobutrol (CAS 138071-82-6) Revenue in 2019
3.2.5 Global Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gadobutrol (CAS 138071-82-6) Price by Manufacturers
3.4 Global Gadobutrol (CAS 138071-82-6) Manufacturing Base Distribution, Product Types
3.4.1 Gadobutrol (CAS 138071-82-6) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
3.4.3 Date of International Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Type (2015-2020)
4.1.1 Global Gadobutrol (CAS 138071-82-6) Sales by Type (2015-2020)
4.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2015-2020)
4.1.3 Gadobutrol (CAS 138071-82-6) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gadobutrol (CAS 138071-82-6) Market Size Forecast by Type (2021-2026)
4.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2021-2026)
4.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2021-2026)
4.2.3 Gadobutrol (CAS 138071-82-6) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gadobutrol (CAS 138071-82-6) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Application (2015-2020)
5.1.1 Global Gadobutrol (CAS 138071-82-6) Sales by Application (2015-2020)
5.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2015-2020)
5.1.3 Gadobutrol (CAS 138071-82-6) Price by Application (2015-2020)
5.2 Gadobutrol (CAS 138071-82-6) Market Size Forecast by Application (2021-2026)
5.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2021-2026)
5.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2021-2026)
5.2.3 Global Gadobutrol (CAS 138071-82-6) Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Gadobutrol (CAS 138071-82-6) Market Size YoY Growth 2015-2026
6.1.1 Japan Gadobutrol (CAS 138071-82-6) Sales YoY Growth 2015-2026
6.1.2 Japan Gadobutrol (CAS 138071-82-6) Revenue YoY Growth 2015-2026
6.1.3 Japan Gadobutrol (CAS 138071-82-6) Market Share in Global Market 2015-2026
6.2 Japan Gadobutrol (CAS 138071-82-6) Market Size by Players (International and Local Players)
6.2.1 Japan Top Gadobutrol (CAS 138071-82-6) Players by Sales (2015-2020)
6.2.2 Japan Top Gadobutrol (CAS 138071-82-6) Players by Revenue (2015-2020)
6.3 Japan Gadobutrol (CAS 138071-82-6) Historic Market Review by Type (2015-2020)
6.3.1 Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2015-2020)
6.3.2 Japan Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2015-2020)
6.3.3 Japan Gadobutrol (CAS 138071-82-6) Price by Type (2015-2020)
6.4 Japan Gadobutrol (CAS 138071-82-6) Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2021-2026)
6.4.2 Japan Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2021-2026)
6.4.3 Japan Gadobutrol (CAS 138071-82-6) Price Forecast by Type (2021-2026)
6.5 Japan Gadobutrol (CAS 138071-82-6) Historic Market Review by Application (2015-2020)
6.5.1 Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2015-2020)
6.5.2 Japan Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2015-2020)
6.5.3 Japan Gadobutrol (CAS 138071-82-6) Price by Application (2015-2020)
6.6 Japan Gadobutrol (CAS 138071-82-6) Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2021-2026)
6.6.2 Japan Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2021-2026)
6.6.3 Japan Gadobutrol (CAS 138071-82-6) Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gadobutrol (CAS 138071-82-6) Market Size YoY Growth 2015-2026
7.2 North America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
7.2.1 North America Gadobutrol (CAS 138071-82-6) Sales by Country (2015-2020)
7.2.2 North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gadobutrol (CAS 138071-82-6) Market Size YoY Growth 2015-2026
8.2 Europe Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
8.2.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Country
8.2.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gadobutrol (CAS 138071-82-6) Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
9.2.1 Asia Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2015-2020)
9.2.2 Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gadobutrol (CAS 138071-82-6) Market Size YoY Growth 2015-2026
10.2 Latin America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
10.2.1 Latin America Gadobutrol (CAS 138071-82-6) Sales by Country
10.2.2 Latin America Gadobutrol (CAS 138071-82-6) Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
11.2.1 Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales by Country
11.2.2 Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer HealthCare Pharmaceuticals Inc.
12.1.1 Bayer HealthCare Pharmaceuticals Inc. Corporation Information
12.1.2 Bayer HealthCare Pharmaceuticals Inc. Description and Business Overview
12.1.3 Bayer HealthCare Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Products Offered
12.1.5 Bayer HealthCare Pharmaceuticals Inc. Recent Development
12.2 SWAPNROOP DRUGS & PHARMACEUTICALS
12.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
12.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Description and Business Overview
12.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Sales, Revenue and Gross Margin (2015-2020)
12.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Products Offered
12.2.5 SWAPNROOP DRUGS & PHARMACEUTICALS Recent Development
12.3 Manus Aktteva Biopharma LLP
12.3.1 Manus Aktteva Biopharma LLP Corporation Information
12.3.2 Manus Aktteva Biopharma LLP Description and Business Overview
12.3.3 Manus Aktteva Biopharma LLP Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Products Offered
12.3.5 Manus Aktteva Biopharma LLP Recent Development
12.4 Jilin Tely Imp & Exp CO.,LTD
12.4.1 Jilin Tely Imp & Exp CO.,LTD Corporation Information
12.4.2 Jilin Tely Imp & Exp CO.,LTD Description and Business Overview
12.4.3 Jilin Tely Imp & Exp CO.,LTD Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Products Offered
12.4.5 Jilin Tely Imp & Exp CO.,LTD Recent Development
12.5 JinYan Chemicals (ShangHai) Co., Ltd.
12.5.1 JinYan Chemicals (ShangHai) Co., Ltd. Corporation Information
12.5.2 JinYan Chemicals (ShangHai) Co., Ltd. Description and Business Overview
12.5.3 JinYan Chemicals (ShangHai) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Products Offered
12.5.5 JinYan Chemicals (ShangHai) Co., Ltd. Recent Development
12.6 BOC Sciences
12.6.1 BOC Sciences Corporation Information
12.6.2 BOC Sciences Description and Business Overview
12.6.3 BOC Sciences Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BOC Sciences Gadobutrol (CAS 138071-82-6) Products Offered
12.6.5 BOC Sciences Recent Development
12.7 LGM Pharma
12.7.1 LGM Pharma Corporation Information
12.7.2 LGM Pharma Description and Business Overview
12.7.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 LGM Pharma Gadobutrol (CAS 138071-82-6) Products Offered
12.7.5 LGM Pharma Recent Development
12.8 Advanced Technology & Industrail Co., Ltd.
12.8.1 Advanced Technology & Industrail Co., Ltd. Corporation Information
12.8.2 Advanced Technology & Industrail Co., Ltd. Description and Business Overview
12.8.3 Advanced Technology & Industrail Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Products Offered
12.8.5 Advanced Technology & Industrail Co., Ltd. Recent Development
12.9 MedKoo Biosciences, Inc.
12.9.1 MedKoo Biosciences, Inc. Corporation Information
12.9.2 MedKoo Biosciences, Inc. Description and Business Overview
12.9.3 MedKoo Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Products Offered
12.9.5 MedKoo Biosciences, Inc. Recent Development
12.11 Bayer HealthCare Pharmaceuticals Inc.
12.11.1 Bayer HealthCare Pharmaceuticals Inc. Corporation Information
12.11.2 Bayer HealthCare Pharmaceuticals Inc. Description and Business Overview
12.11.3 Bayer HealthCare Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Products Offered
12.11.5 Bayer HealthCare Pharmaceuticals Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gadobutrol (CAS 138071-82-6) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gadobutrol (CAS 138071-82-6) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Gadobutrol (CAS 138071-82-6) Market Segments
Table 2. Ranking of Global Top Gadobutrol (CAS 138071-82-6) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gadobutrol (CAS 138071-82-6) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Table 5. Major Manufacturers of Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
Table 6. Major Manufacturers of Pharmacy Bulk Packages (30 mL and 65 mL)
Table 7. Global Gadobutrol (CAS 138071-82-6) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Gadobutrol (CAS 138071-82-6) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Gadobutrol (CAS 138071-82-6) Sales by Regions 2015-2020 (K MT)
Table 10. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Regions (2015-2020)
Table 11. Global Gadobutrol (CAS 138071-82-6) Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2021-2026) (K MT)
Table 13. Global Gadobutrol (CAS 138071-82-6) Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Gadobutrol (CAS 138071-82-6) Sales Share by Manufacturers (2015-2020)
Table 15. Global Gadobutrol (CAS 138071-82-6) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Gadobutrol (CAS 138071-82-6) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gadobutrol (CAS 138071-82-6) as of 2019)
Table 17. Gadobutrol (CAS 138071-82-6) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Gadobutrol (CAS 138071-82-6) Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Gadobutrol (CAS 138071-82-6) Price (2015-2020) (USD/MT)
Table 20. Gadobutrol (CAS 138071-82-6) Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
Table 22. Date of International Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2015-2020) (K MT)
Table 25. Global Gadobutrol (CAS 138071-82-6) Sales Share by Type (2015-2020)
Table 26. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Type (2015-2020)
Table 28. Gadobutrol (CAS 138071-82-6) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Gadobutrol (CAS 138071-82-6) Sales Share by Type (2021-2026)
Table 30. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2015-2020) (K MT)
Table 31. Global Gadobutrol (CAS 138071-82-6) Sales Share by Application (2015-2020)
Table 32. Global Gadobutrol (CAS 138071-82-6) Sales Share by Application (2021-2026)
Table 33. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Gadobutrol (CAS 138071-82-6) Sales (K MT) of Key Companies (2015-2020)
Table 37. Japan Gadobutrol (CAS 138071-82-6) Sales Share by Company (2015-2020)
Table 38. Japan Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Gadobutrol (CAS 138071-82-6) Sales (K MT) by Type (2015-2020)
Table 40. Japan Gadobutrol (CAS 138071-82-6) Sales Share by Type (2015-2020)
Table 41. Japan Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Gadobutrol (CAS 138071-82-6) Price (K MT) by Type (2015-2020)
Table 43. Japan Gadobutrol (CAS 138071-82-6) Sales (K MT) by Type (2021-2026)
Table 44. Japan Gadobutrol (CAS 138071-82-6) Sales Share by Type (2021-2026)
Table 45. Japan Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Gadobutrol (CAS 138071-82-6) Revenue Share by Type (2021-2026)
Table 47. Japan Gadobutrol (CAS 138071-82-6) Price (K MT) by Type (2021-2026)
Table 48. Japan Gadobutrol (CAS 138071-82-6) Sales (K MT) by Application (2015-2020)
Table 49. Japan Gadobutrol (CAS 138071-82-6) Sales Share by Application (2015-2020)
Table 50. Japan Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Gadobutrol (CAS 138071-82-6) Sales (K MT) by Application (2021-2026)
Table 52. Japan Gadobutrol (CAS 138071-82-6) Sales Share by Application (2021-2026)
Table 53. Japan Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Gadobutrol (CAS 138071-82-6) Revenue Share by Application (2021-2026)
Table 55. North America Gadobutrol (CAS 138071-82-6) Sales by Country (2015-2020) (K MT)
Table 56. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2015-2020)
Table 57. North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2015-2020)
Table 59. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2015-2020) (K MT)
Table 60. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2015-2020)
Table 61. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2015-2020) (K MT)
Table 64. Asia Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2015-2020)
Table 67. Latin America Gadobutrol (CAS 138071-82-6) Sales by Country (2015-2020) (K MT)
Table 68. Latin America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Gadobutrol (CAS 138071-82-6) Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2015-2020) (K MT)
Table 72. Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2015-2020)
Table 75. Bayer HealthCare Pharmaceuticals Inc. Corporation Information
Table 76. Bayer HealthCare Pharmaceuticals Inc. Description and Business Overview
Table 77. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product
Table 79. Bayer HealthCare Pharmaceuticals Inc. Recent Development
Table 80. SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
Table 81. SWAPNROOP DRUGS & PHARMACEUTICALS Description and Business Overview
Table 82. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. SWAPNROOP DRUGS & PHARMACEUTICALS Product
Table 84. SWAPNROOP DRUGS & PHARMACEUTICALS Recent Development
Table 85. Manus Aktteva Biopharma LLP Corporation Information
Table 86. Manus Aktteva Biopharma LLP Description and Business Overview
Table 87. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Manus Aktteva Biopharma LLP Product
Table 89. Manus Aktteva Biopharma LLP Recent Development
Table 90. Jilin Tely Imp & Exp CO.,LTD Corporation Information
Table 91. Jilin Tely Imp & Exp CO.,LTD Description and Business Overview
Table 92. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Jilin Tely Imp & Exp CO.,LTD Product
Table 94. Jilin Tely Imp & Exp CO.,LTD Recent Development
Table 95. JinYan Chemicals (ShangHai) Co., Ltd. Corporation Information
Table 96. JinYan Chemicals (ShangHai) Co., Ltd. Description and Business Overview
Table 97. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. JinYan Chemicals (ShangHai) Co., Ltd. Product
Table 99. JinYan Chemicals (ShangHai) Co., Ltd. Recent Development
Table 100. BOC Sciences Corporation Information
Table 101. BOC Sciences Description and Business Overview
Table 102. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. BOC Sciences Product
Table 104. BOC Sciences Recent Development
Table 105. LGM Pharma Corporation Information
Table 106. LGM Pharma Description and Business Overview
Table 107. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. LGM Pharma Product
Table 109. LGM Pharma Recent Development
Table 110. Advanced Technology & Industrail Co., Ltd. Corporation Information
Table 111. Advanced Technology & Industrail Co., Ltd. Description and Business Overview
Table 112. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Advanced Technology & Industrail Co., Ltd. Product
Table 114. Advanced Technology & Industrail Co., Ltd. Recent Development
Table 115. MedKoo Biosciences, Inc. Corporation Information
Table 116. MedKoo Biosciences, Inc. Description and Business Overview
Table 117. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. MedKoo Biosciences, Inc. Product
Table 119. MedKoo Biosciences, Inc. Recent Development
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Gadobutrol (CAS 138071-82-6) Players
Table 124. Gadobutrol (CAS 138071-82-6) Customers List
Table 125. Gadobutrol (CAS 138071-82-6) Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of FiguresFigure 1. Gadobutrol (CAS 138071-82-6) Product Picture
Figure 2. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020 & 2026
Figure 3. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) Product Picture
Figure 4. Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL) Product Picture
Figure 5. Pharmacy Bulk Packages (30 mL and 65 mL) Product Picture
Figure 6. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020 & 2026
Figure 7. Adults
Figure 8. Children
Figure 9. Gadobutrol (CAS 138071-82-6) Report Years Considered
Figure 10. Global Gadobutrol (CAS 138071-82-6) Market Size 2015-2026 (US$ Million)
Figure 11. Global Gadobutrol (CAS 138071-82-6) Sales 2015-2026 (K MT)
Figure 12. Global Gadobutrol (CAS 138071-82-6) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2015-2020)
Figure 14. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region in 2019
Figure 15. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2015-2020)
Figure 16. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region in 2019
Figure 17. Global Gadobutrol (CAS 138071-82-6) Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Gadobutrol (CAS 138071-82-6) Revenue in 2019
Figure 19. Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2015-2020)
Figure 21. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2019
Figure 22. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2015-2020)
Figure 23. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type in 2019
Figure 24. Global Gadobutrol (CAS 138071-82-6) Market Share by Price Range (2015-2020)
Figure 25. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2015-2020)
Figure 26. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2019
Figure 27. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2015-2020)
Figure 28. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application in 2019
Figure 29. Japan Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2015-2026 (K MT)
Figure 30. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. Japan Gadobutrol (CAS 138071-82-6) Market Share in Global Market 2015-2026
Figure 32. Japan 5 and 10 Largest Gadobutrol (CAS 138071-82-6) Players Market Share by Revenue in Gadobutrol (CAS 138071-82-6) in 2019
Figure 33. Japan Gadobutrol (CAS 138071-82-6) Revenue Share by Type (2015-2020)
Figure 34. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Japan Gadobutrol (CAS 138071-82-6) Revenue Share by Application (2015-2020)
Figure 36. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2015-2020 (K MT)
Figure 38. North America Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2019
Figure 40. North America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2019
Figure 41. U.S. Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 42. U.S. Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 44. Canada Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2019
Figure 48. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2019
Figure 49. Germany Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region in 2019
Figure 62. Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region in 2019
Figure 63. China Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Gadobutrol (CAS 138071-82-6) Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Gadobutrol (CAS 138071-82-6) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country in 2019
Figure 88. Latin America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country in 2019
Figure 89. Mexico Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Gadobutrol